Finally, an in silico analysis of a cohort of 1570 NSCLC patients reveals that high expression of ALDH1A2, but not of ALDH1A1 or ALDH1A3, is associated with poorer prognosis (Supplementary Figure S3G). This evidence concerns the gene ALDH1A3 and non-small cell lung carcinoma.